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ABSTRACT
Introduction: Disseminated superficial actinic 
porokeratosis (DSAP) is the most common form 
of porokeratosis. A case of late-onset DSAP is 
reported with an uncommon presentation in an 
elderly patient. Methods: An 80-year-old woman, 
with diabetes mellitus treated with metformin, 
and hypertension treated with metoprolol and 
captopril, presented with multiple 2 mm-to-7 
cm brown patches, for 5 years. The patches were 
often confluent with an atrophic center and a 
well-demarcated keratotic border located on the 
thighs, lower legs, and feet. Results: Histological 
examination of a cutaneous biopsy showed the 
presence of rare cornoid lamellae, confirming 
the clinical diagnosis of DSAP. Conclusion: In 
this report, the atypical presentation of DSAP 
is discussed in this elderly patient and also the 
possible triggering factors at this age.
Keywords: case study; disseminated superficial 
actinic porokeratosis; elderly
INTRODUCTION
Porokeratosis (PK) is a heterogeneous group of 
hereditary or acquired disorders, with a broad 
clinical spectrum and various etiologies. It 
manifests clinically with patches surrounded 
by a keratotic border, usually more palpable 
than visible, and an atrophic depressed center.1
Histologically, the hallmark of PK is cornoid 
lamella, which corresponds to a thin column 
of parakeratotic cells above an invaginated 
epidermis devoid of an underlying granular 
layer. Cornoid lamella corresponds to the 
hyperkeratotic border and is thought to be a focal 
clonal proliferation of keratinocytes.2,3 Several 
subtypes of PK have been distinguished based on 
size, localization, and number of lesions: classic 
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PK of Mibelli, disseminated superficial actinic PK 
(DSAP), disseminated superficial PK (DSP), linear 
PK, PK palmaris et plantaris disseminata, and 
punctuate palmoplantar PK.2,3 The pathogenesis 
of PK is still unknown but it is now considered as 
a genodermatosis with an autosomal dominant 
mode of inheritance.2
DSAP is the most common form of PK. 
It mainly involves fair-skinned women and 
usually occurs by the third or the fourth 
decade.3 Cutaneous lesions are usually located in 
photoexposed areas, mainly extremities, and are 
usually multiple (in the hundreds) and small-
sized (<2 cm). An atypical presentation of DSAP 
characterized by a late onset is reported in an 
elderly patient with unusually large lesions. 
REPORT
An 80-year-old woman (skin type 4) with no 
excessive sun exposure, with type 2 diabetes 
mellitus treated with metformin for 20 years 
and hypertension treated with metoprolol and 
captopril for 10 years, presented for 5 years with 
pruritic lesions of the legs. Informed consent 
was obtained from the patient. There were 
no similar familial cases. Her daughter denied 
any cutaneous disorder in the years preceding 
the onset of the presented lesions. Cutaneous 
examination showed on the thighs, lower 
legs, and feet; multiple 2 mm-to-7 cm brown 
plaques, sometimes confluent with an atrophic 
and desquamative center and well-demarcated 
keratotic and filiform border (Figure 1a, 1b, 1c). 
The rest of the tegument was normal, particularly 
the mucous membranes, palms of hands, and 
soles of feet. Physical examination was otherwise 
normal. Histological examination of a cutaneous 
biopsy showed an atrophic epidermis with the 
presence of rare cornoid lamellae presenting 
as thin columns of parakeratin over a focal 
invagination of epidermis with loss of granular 
Figure 1a, b and c. Multiple 2 mm-to-7 cm brown 
patches, sometimes confluent with an atrophic center, 
and a well-demarcated keratotic border located on the 
thighs (a), lower legs (b), and feet (c).
layer and apoptotic keratinocytes (Figure 2). 
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diagnosis of PK in its particular form of DSAP. 
Laboratory tests revealed no significant findings. 
The patient had topical keratolytics with no 
improvement. 
DISCUSSION
The patient within this case study had a late-
onset DSAP (at 75 years of age) which is a known 
but rarely reported phenomenon.4 DSAP is an 
inherited autosomal dominant condition with 
reduced penetrance at younger ages. Indeed, 
the disorder requires sun exposure for full 
expression and it usually begins in the third 
to fourth decade, but rarely at later ages.2,4
Chronic exposure to sunlight is an important 
triggering factor for full expression of DSAP. 
This is illustrated by the relative frequency of 
this disorder in geographical areas with large 
amounts of sun exposure, particularly Australia.3
Shumack and Commens even stated that in 
patients with sun-damaged skin lesions, DSAP 
is commonly mistaken for multiple actinic 
keratoses.3
Localization on lower limbs with no 
involvement of the face should indicate the 
diagnosis of DSAP, rather than actinic keratosis. 
The onset of DSAP in elderly patients can 
be explained by the fact that the pathologic 
clone for PK is present but remains latent until 
the amount of sun exposure brings about its 
proliferation.4 The elderly patient within this 
study is sun protected most of the time; she 
is a housewife, so she spends most of the day 
indoors. This can explain the delayed expression 
of DSAP. The physiological lowering of the 
immunocompetence due to age can be another 
triggering factor of delayed expression of DSAP 
in adulthood. 
Patrizi et al. reported 12 cases of DSAP in 
elderly patients aged between 70 to 90 years old 
(2 males and 10 females) with a mean age at onset 
of about 70 years old.4 In this report, the clinical 
picture was similar to that of the patient within 
this case report with an exclusive involvement 
of the lower limbs. The authors stated that late-
onset DSAP described in their patients may 
represent a type of immunosuppression-induced 
PK. This latter had already been described either 
after organ transplantation (especially kidney 
and bone marrow transplantations), long-term 
use of corticosteroids, or in AIDS.2,5,6 Recently, 
with the widespread use of organ transplantation 
and immunosuppressive treatments, the 
incidence of PK has increased from 0.34% to 
10.68% of patients who have undergone organ 
transplantation.7
The elderly patient in this case study did not 
have any immunosuppressive drugs, but she had 
diabetes mellitus which can contribute to and 
aggravate the age-related immunosuppression. 
The mechanism of immunosuppression-induced 
PK remains unclear, but it has been hypothesized 
that loss of immunosurveillance caused by 
immunosuppression allows the proliferation of 
abnormal keratinocyte clones, which leads to PK.8
Figure 2. Cornoid lamella presenting as a thin column 
of parakeratin over a focal invagination of an atrophic 
epidermis with loss of granular layer and apoptotic 
keratinocytes.
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Moreover, PK develops due to higher rates of 
mitotic division in abnormal clones than in 
normal keratinocytes.6 Most porokeratoses 
described after immunosuppression were of 
DSP subtype. However, there have been rare 
cases of immunosuppression-induced DSAP 
described.9 The diagnosis of DSP is unlikely in 
the patient, due to the predominant localization 
on the lower limbs with sparing of the face and 
the trunk. Cutaneous lesion size in the patient 
was important, especially on the dorsum of the 
feet and the lower legs, while more typical in 
patients with DSAP, the lesions were small in 
size on the thighs. To be in the conventional 
classification of PK, the patient was considered 
as having DSAP and the huge lesions were due 
to the confluence of the patches. Drug-induced 
DSAP seems to be unlikely in the patient, due 
to the long delay between the ingestion of the 
drugs (antidiabetic and antihypertensive drugs) 
and the onset of the lesions. Drug-induced 
PK has been rarely reported in the literature. 
Incriminating drugs were thiazidic derivative, 
suramine, and antibiotics.10-12 In all reported 
cases, delay between drug administration and 
onset of PK was short: between 10 to 15 days.
Different therapeutic modalities were 
attempted in DSAP with variable results. These 
treatments are either topical (keratolytics, 
5-fluorouracil 5%, vitamin D3 analogs), physical 
(photodynamic therapy, Q-switched laser, CO2 
laser), or systemic (oral acitretin), and their 
use remains largely in the field of anecdotal 
experience. The precise value of each therapeutic 
modality is presently difficult to determine 
owing to the paucity of controlled studies.1 The 
patient was topically treated with keratolytics 
with no real improvement.
PK is a chronic disorder known to be 
a precursor of squamous-cell carcinoma. 
Malignant transformation can occur in 3.4% 
(DSAP) to 19% (linear PK) of cases.2 The higher 
incidence of skin carcinoma may be due to 
multiple factors, such as earlier onset, larger 
size, and the underlying genetic predisposition 
related to loss of heterozygosity.2,5 Long-term 
surveillance is then warranted in all patients 
with PK. Surprisingly, there is no increase in skin 
cancers arising in PK lesions in individuals who 
have undergone organ transplantation, who are 
at higher risk for skin cancers otherwise.2
CONCLUSION
In conclusion, clinicians should be aware of 
the possible late onset of DSAP, especially in 
dark-skinned elderly people with no history 
of intensive sun exposure. Risk factors seem 
to be related to ultraviolet radiations, age-
related immunosuppression, and probably, 
although rare, some drugs, in particular 
immunosuppressive drugs.
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